Cancer Treatment in India For uk patient

Best Cancer Treatment in India For UK Patient

A cancer diagnosis is one of the most urgent and frightening situations a person and their family can face. In the UK, what follows — the NHS pathway, the waiting, the uncertainty about timing — can make an already difficult situation harder to bear.

 

Thousands of UK cancer patients are now choosing to pursue treatment in India. Not as a last resort, and not as a compromise — but as a deliberate decision to access high-quality oncology care faster, with access to treatments that may not yet be widely available under the NHS, at a cost that does not wipe out life savings or require remortgaging a home.

 

This page is written specifically for UK patients and their families. It covers what India's oncology centres can offer that the NHS currently cannot deliver at speed, how costs compare in GBP, and how to take the first step toward getting a real treatment plan based on your actual diagnosis.

 

Get Your Free Cancer Treatment Assessment — Response Within 24–48 Hours Share your pathology report or biopsy. Reviewed by our oncology team. No obligation.

The NHS Cancer Pathway: What UK Patients Are Actually Facing

subtype early can meaningfully change your treatment plan. On the NHS, comprehensive molecular profiling is not uniformly available for all cancer types or all patients.

Access to Treatments Not Yet Widely Available on the NHS

Several treatments available in India are either not yet approved on the NHS, available only through clinical trials, or accessible only after multiple prior treatment failures under NHS guidelines:

• CAR-T cell therapy for B-cell lymphomas and leukemias—available at select Indian centres from £30,000–£65,000, versus £300,000+ in private UK settings where available at all
• Proton therapy—available at Apollo Proton Cancer Centre (Chennai) and Tata Memorial (Mumbai) at a fraction of private UK proton therapy cost
• Next-generation immunotherapy combinations — pembrolizumab, nivolumab, and combination checkpoint inhibitor protocols available at costs dramatically lower than UK private pricing
• Domestic CAR-T (NexCAR19) — India's indigenously developed CAR-T therapy, available at approximately £30,000–£40,000

Multidisciplinary Tumour Board Review

Every new cancer case at India's accredited oncology centres is reviewed by a multidisciplinary tumor board—medical oncologist, surgical oncologist, radiation oncologist, radiologist, and pathologist—before a treatment plan is agreed upon. This ensures your plan reflects collective specialist judgment, not a single clinician's recommendation.

Cancer Treatment Cost: India vs UK Private — In GBP

For UK patients who are considering private treatment to bypass NHS waits, or who are simply comparing options, here is how costs compare across the most common cancer treatment modalities:

 

Treatment	UK Private Cost (£)	India Cost (£)
Chemotherapy — per cycle (standard)	£2,000 – £5,000	£185 – £550
Chemotherapy — per cycle (immunotherapy)	£8,000 – £18,000	£950 – £2,700
Cancer Surgery (mastectomy)	£15,000 – £30,000	£1,950 – £3,900
Cancer Surgery (lung lobectomy)	£25,000 – £45,000	£3,500 – £7,000
Radiation — IMRT full course	£15,000 – £30,000	£1,950 – £3,900
SBRT / CyberKnife (3–5 sessions)	£15,000 – £30,000	£3,100 – £9,300
Proton Therapy (full course)	£90,000 – £120,000+	£11,700 – £23,400
Bone Marrow Transplant (autologous)	£80,000 – £120,000+	£11,700 – £19,500
CAR-T Cell Therapy	£250,000 – £350,000+ (rarely available)	£30,000 – £65,000

 

Figures are GBP equivalents based on typical USD pricing at accredited Indian hospitals and published UK private cancer centre rates. Individual quotes will vary by cancer type, stage, protocol, and hospital chosen.

Cancer Types Most Commonly Treated in India by UK Patients

Breast Cancer

India's oncology centres treat breast cancer to the same protocol standards as the UK — surgery (lumpectomy or mastectomy), adjuvant chemotherapy, radiation, and targeted therapy (trastuzumab for HER2-positive disease). Robotic-assisted breast surgery and oncoplastic reconstruction are available. Hormone receptor testing and HER2 status profiling are fast and comprehensive. Total treatment cost for a typical early-stage case: £5,000 to £11,000. For HER2-positive cases requiring trastuzumab: typically £12,000 to £25,000 for the full course.

 

Lung Cancer

Molecular profiling is particularly critical in lung cancer. India's oncology centres perform rapid EGFR, ALK, ROS1, KRAS, and PD-L1 testing — results typically within 5 to 10 days. For patients with targetable mutations, oral targeted therapy (osimertinib for EGFR, alectinib for ALK) is available at a fraction of UK private cost. For non-small cell lung cancer without targetable mutations, immunotherapy (pembrolizumab alone or in combination) is available. Minimally invasive thoracic surgery including VATS lobectomy is routinely performed.

 

Colorectal Cancer

Laparoscopic and robotic colorectal surgery is well-established at India's leading centres. For locally advanced rectal cancer, neoadjuvant chemoradiation followed by surgery is the standard of care — the same as NICE guidelines in the UK. For metastatic colorectal cancer, FOLFOX/FOLFIRI chemotherapy with targeted agents (bevacizumab, cetuximab) is available at dramatically lower cost than UK private oncology.

 

Blood Cancers (Lymphoma, Leukaemia, Myeloma)

India is a particularly strong destination for haematological malignancies. Bone marrow transplant programmes at centres like Fortis FMRI, BLK-Max, and Tata Memorial are among the most experienced in Asia. For eligible patients, CAR-T therapy is now available at Indian centres at costs that are genuinely accessible compared to Western alternatives. R-CHOP for lymphoma, VRD for myeloma, and TKI therapy for CML are all available at a fraction of UK private cost.

 

Gynaecological Cancers

Robotic and laparoscopic gynaecological oncology surgery — for cervical, ovarian, and endometrial cancers — is routinely available at India's top cancer centres. Concurrent chemoradiation and brachytherapy for cervical cancer is well-established and available at a total course cost significantly below UK private rates.

How It Works for UK Patients — Step by Step

1. Share Your Pathology and Imaging Reports

Send your biopsy report, pathology results, and any imaging (CT, PET-CT, MRI). If you are still waiting for NHS results, you can also request a second pathology opinion in India from the same tissue blocks — Indian pathology labs provide rapid turnaround.

 

2. Receive an Oncology Assessment and Treatment Plan

Our medical team reviews your case with an appropriate oncology specialist — medical oncologist, surgical oncologist, or radiation oncologist depending on your cancer type. Within 24 to 48 hours you receive a written treatment plan and cost estimate in GBP.

 

3. Video Consultation With Your Oncologist

Before you travel, you speak directly with your treating oncologist in India. Ask about their experience with your specific cancer type, the proposed protocol, the timeline, and what happens if your treatment requires adjustment.

 

4. Medical Visa and Travel

We coordinate your hospital invitation letter for the India Medical Visa application, advise on routing from the UK, and arrange airport pickup and accommodation near the hospital.

 

5. Treatment and Coordination

A dedicated patient coordinator manages your hospital stay, outpatient appointments, and all logistics. If your treatment involves multiple cycles with return visits between them, your coordinator manages scheduling for each visit.

 

6. NHS Handover on Return

Before you leave India, you receive a complete discharge pack in English — treatment summary, all pathology results, imaging reports, current medication protocol, and follow-up recommendations. This can be shared directly with your NHS GP or oncologist.

Managing Chemotherapy Cycles Between UK and India

For patients who cannot stay in India for the full duration of a multi-month chemotherapy course, a practical approach used by many UK patients is cycle-by-cycle travel — flying to India for each chemotherapy cycle and returning to the UK between cycles.

• Most chemotherapy cycles are delivered every 3 weeks — this allows a pattern of traveling to India for 3 to 5 days per cycle, then returning home for the remaining 2 to 2.5 weeks
• Between-cycle blood monitoring (FBC, liver function, renal function) can be done at your NHS GP surgery or a private blood testing clinic in the UK, with results shared electronically with your Indian oncologist before each cycle
• Your Indian oncologist and UK GP communicate via your discharge documentation at each cycle — your Racure coordinator facilitates this
• For patients on oral targeted therapy (imatinib, osimertinib, palbociclib), medication can be dispensed in India for the full course, significantly reducing cost compared to UK private prescriptions

Quality of Cancer Care in India — What UK Patients Should Know

• India's leading oncology centres follow NCCN (National Comprehensive Cancer Network) and ESMO guidelines — the same international protocols followed by NHS oncologists
• JCI and NABH accreditation independently verify that patient safety, infection control, and clinical standards meet international benchmarks
• Senior Indian oncologists are frequently FRCP or MRCP-qualified, have published in international peer-reviewed journals, and attend ASCO and ESMO conferences
• Treatment records are maintained in English and are fully compatible with NHS systems — your NHS oncologist can continue your care seamlessly on return
• Tata Memorial Centre in Mumbai is internationally ranked among Asia's top cancer centres and has formal research collaborations with global institutions

Your NHS Entitlements Are Not Affected

A common concern among UK patients is whether seeking cancer treatment abroad affects NHS eligibility. The answer is clear: receiving treatment privately abroad does not affect your NHS rights in any way.

• You remain entitled to NHS GP care, follow-up oncology appointments, and ongoing monitoring after returning from India
• If your NHS oncologist wishes to continue managing your care on return, they can do so using the treatment records from India — which are all in English
• Prescriptions for ongoing medications can be reviewed by your NHS GP and issued on the NHS where the drugs are available on the UK formulary
• If you return to the NHS for any aspect of follow-up care, simply share your Indian medical records with your GP or oncologist

Frequently Asked Questions from UK Patients

Can I get a second opinion from an Indian oncologist before deciding to travel?

Yes — and this is exactly what we recommend. A video consultation with a senior Indian oncologist is available before you book flights or commit to anything. Many UK patients use this as a second opinion on their NHS diagnosis and proposed treatment plan, independent of any decision to travel for treatment.

What if I need treatment urgently and cannot wait even for the visa process?

India's Medical Visa typically takes 3 to 10 business days to process. In cases of genuine clinical urgency, hospitals can expedite the invitation letter, and some UK-based Indian consulates offer priority processing. Contact us and we will assess your timeline and help move as fast as possible.

Will my NHS treatment be delayed or affected if I start treatment in India?

No. Beginning treatment in India does not pause, cancel, or affect your NHS referral. You can choose to continue on the NHS pathway in parallel and make your decision closer to when treatment is scheduled. Many patients use India for the initial cycle or surgery while NHS scheduling catches up, then transition care back to the NHS for follow-up.

Can I get cancer treatment in India if I am over 70?

Yes. Age alone is not a contraindication for cancer treatment in India. India's oncology centres routinely treat elderly patients, including those with multiple comorbidities. Your fitness for treatment will be assessed based on your overall health status, not your age.

Is travel insurance available for UK cancer patients traveling to India for treatment?

Specialist travel insurance for patients with pre-existing cancer diagnoses exists in the UK — providers include AllClear, Staysure, and others who specifically cover pre-existing medical conditions. Check that your policy covers medical treatment abroad and repatriation. Always disclose your diagnosis fully when purchasing a policy.

Take the First Step — Get a Free Oncology Assessment

You don't need to decide about traveling to India before you speak to an oncologist there. The first step is simply sending your reports and receiving a written treatment plan and cost estimate — so you can compare it to your NHS pathway with real information in hand.

Get Your Free Cancer Assessment and GBP Cost Estimate Pathology and imaging reviewed within 24–48 hours. Confidential. No obligation to proceed.